Snakebites Get DNA Fingerprint Treatment

Researchers have developed a technique for determining the species of snake responsible for a bite by sequencing genetic material from the fang marks.

Written byBob Grant
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The Indian, or spectacled, cobra (Naja naja)WIKIMEDIA, JULIE ANNE WORKMANKnowing the species of snake that bit someone is essential for proper treatment. And that knowledge becomes all the more important when the offending serpent is venomous: administering the correct antivenom can mean the difference between life and death. Researchers working in Nepal, where people are often bitten by the deadly spectacled cobra (Naja naja), have developed a DNA test that can identify the species of snake responsible for a bite using remnant genetic material left inside fang marks on the victim. “You need to know the species that bit your patient [in order to treat them],” Ulrich Kuch, the developer of the test and a biologist at the Goethe University Institute of Occupational, Social and Environmental Medicine in Germany, told LiveScience. “Now, with the DNA-based test, we can substantially increase the number of patients for whom we can identify the snake species [responsible for the bite].”

Kuch and his colleagues collected 194 reptile DNA samples from Nepalese snakebite victims, 21 of whom brought in the dead snake that had bitten them. In all 21 of those cases, Kuch’s DNA test correctly identified the species of snake. The researchers reported their findings today (November 4) at the American Society of Tropical Medicine and Hygiene's annual meeting being held in New Orleans.

In its current form, the test is too slow and cumbersome to help every snakebite victim. But it could be used by epidemiologists wishing to characterize which species of snake that commonly bite people around the world. Further refinement of the test could also lead to rapid diagnostics, such as a blood test—which Kuch and his colleagues are currently working on—to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies